NCT02560272View on ClinicalTrials.gov

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried

PHASE3UnknownINTERVENTIONAL
Enrollment

1,560

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

June 30, 2016

Conditions
Haemophilus Influenzae Type b Infections
Interventions
BIOLOGICAL

Minhai-HIB

0.5ml, intramuscular

BIOLOGICAL

Act-HIB®

0.5ml, intramuscular

Trial Locations (1)

Unknown

RECRUITING

Henan Provincial Center for Disease Control and Prevention, Zhengzhou

Sponsors
All Listed Sponsors
lead

Beijing Minhai Biotechnology Co., Ltd

INDUSTRY